These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
573 related articles for article (PubMed ID: 9001254)
1. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Sartorelli V; Huang J; Hamamori Y; Kedes L Mol Cell Biol; 1997 Feb; 17(2):1010-26. PubMed ID: 9001254 [TBL] [Abstract][Full Text] [Related]
2. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Chen SL; Dowhan DH; Hosking BM; Muscat GE Genes Dev; 2000 May; 14(10):1209-28. PubMed ID: 10817756 [TBL] [Abstract][Full Text] [Related]
3. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Eckner R; Yao TP; Oldread E; Livingston DM Genes Dev; 1996 Oct; 10(19):2478-90. PubMed ID: 8843199 [TBL] [Abstract][Full Text] [Related]
4. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Hamamori Y; Wu HY; Sartorelli V; Kedes L Mol Cell Biol; 1997 Nov; 17(11):6563-73. PubMed ID: 9343420 [TBL] [Abstract][Full Text] [Related]
5. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Black BL; Molkentin JD; Olson EN Mol Cell Biol; 1998 Jan; 18(1):69-77. PubMed ID: 9418854 [TBL] [Abstract][Full Text] [Related]
6. Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. Roth JF; Shikama N; Henzen C; Desbaillets I; Lutz W; Marino S; Wittwer J; Schorle H; Gassmann M; Eckner R EMBO J; 2003 Oct; 22(19):5186-96. PubMed ID: 14517256 [TBL] [Abstract][Full Text] [Related]
7. The human T cell leukemia/lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix-loop-helix factors. Riou P; Bex F; Gazzolo L J Biol Chem; 2000 Apr; 275(14):10551-60. PubMed ID: 10744749 [TBL] [Abstract][Full Text] [Related]
8. Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD. Lau P; Bailey P; Dowhan DH; Muscat GE Nucleic Acids Res; 1999 Jan; 27(2):411-20. PubMed ID: 9862959 [TBL] [Abstract][Full Text] [Related]
9. Interaction between acetylated MyoD and the bromodomain of CBP and/or p300. Polesskaya A; Naguibneva I; Duquet A; Bengal E; Robin P; Harel-Bellan A Mol Cell Biol; 2001 Aug; 21(16):5312-20. PubMed ID: 11463815 [TBL] [Abstract][Full Text] [Related]
11. The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD. Bailey P; Sartorelli V; Hamamori Y; Muscat GE Nucleic Acids Res; 1998 Dec; 26(23):5501-10. PubMed ID: 9826778 [TBL] [Abstract][Full Text] [Related]
12. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Novitch BG; Spicer DB; Kim PS; Cheung WL; Lassar AB Curr Biol; 1999 May; 9(9):449-59. PubMed ID: 10322110 [TBL] [Abstract][Full Text] [Related]
13. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Puri PL; Sartorelli V; Yang XJ; Hamamori Y; Ogryzko VV; Howard BH; Kedes L; Wang JY; Graessmann A; Nakatani Y; Levrero M Mol Cell; 1997 Dec; 1(1):35-45. PubMed ID: 9659901 [TBL] [Abstract][Full Text] [Related]
14. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. Mal A; Sturniolo M; Schiltz RL; Ghosh MK; Harter ML EMBO J; 2001 Apr; 20(7):1739-53. PubMed ID: 11285237 [TBL] [Abstract][Full Text] [Related]
15. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding. Sandmöller A; Meents H; Arnold HH Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499 [TBL] [Abstract][Full Text] [Related]
16. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Dodou E; Xu SM; Black BL Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531 [TBL] [Abstract][Full Text] [Related]
17. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Ma K; Chan JK; Zhu G; Wu Z Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463 [TBL] [Abstract][Full Text] [Related]
18. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Molkentin JD; Black BL; Martin JF; Olson EN Cell; 1995 Dec; 83(7):1125-36. PubMed ID: 8548800 [TBL] [Abstract][Full Text] [Related]
19. Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation. Gong XQ; Li L J Biol Chem; 2002 Apr; 277(14):12310-7. PubMed ID: 11809751 [TBL] [Abstract][Full Text] [Related]
20. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Kaushal S; Schneider JW; Nadal-Ginard B; Mahdavi V Science; 1994 Nov; 266(5188):1236-40. PubMed ID: 7973707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]